List of Figures:
Figure 3-1: Attractive Sector for Investment in Healthcare Industry
Figure 4-1: Diagnostics Market (Billion INR), 2006, 2010 & 2012
Figure 5-1: IVD Market by Segment (%), 2010
Figure 5-2: Forecast for IVD Market by Segment (%), 2012
Figure 5-3: Molecular Diagnostics Market by Segment (%), 2010
Figure 6-1: Number of Coronary Heart Disease Cases (Million), 2005 & 2015
Figure 6-2: Number of Diabetes Cases (Million), 2010 & 2015
Figure 6-3: New and Total Number of Cancer Patients (‘000)
Figure 7-1: Health Insurance Premium (Billion INR), 2008-09 & 2009-10
List of Tables:
Table 5-1: Share of Players in Immunochemistry Instruments & Reagents Market (2010)
Table 6-1: Prevalence of Overweight & Obesity in Males and Females (%), 2005 & 2015
Table 6-2: Reported Cases of Communicable Diseases (2008)
Table 8-1: Growth in Infectious Diseases Diagnostics Market (2004-2008)
Table 8-2: Growth in Hormones Diagnostics Market (2004-2008)
Table 8-3: Growth in Blood Grouping Reagents Diagnostics Market (2004-2008)
Table 8-4: Growth in Pregnancy Diagnostics Market (2004-2008)
Table 8-5: Growth in Cancer Markers Diagnostics Market (2004-2008)
Table 11-1: Super Religare Laboratories - Strengths and Weaknesses
Table 11-2: Dr. Lal PathLabs - Strengths and Weaknesses
Table 11-3: Thyrocare Technologies Limited - Strengths and Weaknesses
Table 11-4: Metropolis Health Services - Strengths and Weaknesses
